Saukkonen, JussiMunsiff, SonalWinston, CarlaDuarte, RaquelMammen, Manoj2026-02-132026-02-132025-08Am J Respir Crit Care Med. 2025 Aug;211(8):1526. doi: 10.1164/rccm.202503-0679LE1073-449Xhttp://hdl.handle.net/10400.18/10938The 4-Month Isoniazid, Rifapentine, Moxifloxacin, and Pyrazinamide Treatment Regimen for Drug-Susceptible Pulmonary Tuberculosis: A Word of Caution. Am J Respir Crit Care Med. 2025 Aug;211(8):1525.doi: 10.1164/rccm.202501-0222LE.LetterNo abstract availableengTuberculosisDrug-susceptibleTB treatmentInfecções RespiratóriasReply to Wilson: The 4-Month Isoniazid, Rifapentine, Moxifloxacin, and Pyrazinamide Treatment Regimen for Drug-Susceptible Pulmonary Tuberculosis: A Word of Cautionjournal article10.1164/rccm.202503-0679le1535-497040505149